TipRanks

Svetlana Lucas Insider Profile

11 Followers
Svetlana Lucas, Director at Jasper Therapeutics, holds 3.00K shares in Scribe Therapeutics Inc. (Ticker: SCTX), holds 20.00K shares in Jasper Therapeutics (Ticker: JSPR), holds 6.00K shares in aTyr Pharma (Ticker: ATYR). Most recently, Svetlana Lucas Bought ― shares of Scribe Therapeutics Inc. on Jul 27, 2026 for an estimated value of $45.00K.
tipranks
Svetlana Lucas

Svetlana Lucas
Jasper Therapeutics (JSPR)
Director

Ranked #88,705 out of 109,349 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-46.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$86K
53.60%
34.35%
12.05%
A breakdown of Svetlana Lucas's holdings

Insider Roles

Scribe Therapeutics Inc.
(SCTX)
Chief Business Officer
aTyr Pharma
(ATYR)
Director
Jasper Therapeutics
(JSPR)
Director
Roles that Svetlana Lucas holds in companies

Most Profitable Insider Trade

Stock:
Scribe Therapeutics Inc.
(SCTX)
Rating:Informative Buy
Date:Jul 27, 2026 - Today
Return:-18.70%
The most profitable trade made by Svetlana Lucas

Svetlana Lucas's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Jasper Therapeutics
Sep 24, 2025
Director
Informative Buy
48.60K
$10.40K
Scribe Therapeutics Inc.
Jul 27, 2026
Chief Business Officer
Informative Buy
45.00K
$46.26K
aTyr Pharma
Apr 28, 2023
Director
Uninformative Buy
12.12K
$29.64K
List of latest transactions for each holding click on a transaction to see Svetlana Lucas's performance on stock

Svetlana Lucas insider profile FAQ

What is the percentage of profitable transactions made by Svetlana Lucas?
The percentage of profitable transactions made by Svetlana Lucas is 0%.
    What is the average return per transaction made by Svetlana Lucas?
    The average return per transaction made by Svetlana Lucas is -46.70%.
      What stocks does Svetlana Lucas hold?
      Svetlana Lucas holds: JSPR, SCTX, ATYR stocks.
        What was Svetlana Lucas’s latest transaction?
        Svetlana Lucas latest transaction was an Informative Buy of $45.00K.
          What was Svetlana Lucas's most profitable transaction?
          Svetlana Lucas’s most profitable transaction was an Informative Buy of SCTX stock on July 27, 2026. The return on the trade was -18.70%.
            What is Svetlana Lucas's role in Jasper Therapeutics?
            Svetlana Lucas's role in Jasper Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.